Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Real-World Patient Population in China

NCT01243749 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT01243749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01243749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Real-World Patient Population in China
Lead sponsor
Medtronic Vascular
Phase
Observational
Overall status
Completed
Start date
December 31, 2010
Completion date
December 15, 2017
Enrollment
1,800 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, cardiovascular diseases, coronary artery disease, ischemic heart disease, stenotic coronary lesion